Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None

Size: px
Start display at page:

Download "Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None"

Transcription

1 AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara, Chair Frederick G. Kushner, Vice Chair Deborah D. Ascheim Donald E. Casey, Jr. Mina K. Chung Employment Consultant Speaker s Bureau Harvard School Tulane School of Clinical ; Heart Clinic of Louisiana Director Mount Sinai School of Professor; InCHOIR Clinical Director of Research Atlantic Health Chief Officer and Vice President of Quality Cleveland Clinic Foundation Ownership/ Partnership/ Principal Personal Research Lantheus Imaging (DSMB) NIH (DSMB)* Institutional, Organizational or Other Financial Benefit American Heart Association Novartis Biotronik Boston Scientific Nexcura PGx Sanofi-aventis St. Jude Biosense Webster Biotronik Boston Scientific CardioDx CardioInsight GlaxoSmithKline Medtronic Boston Scientific Medtronic St. Jude Expert Witness

2 James A. de Lemos Steven M. Ettinger James C. Fang Francis B. Fesmire Barry A. Franklin Christopher B. Granger UT Southwestern School Penn State Heart and Vascular Institute and Radiology Hospitals Case Director, Heart Transplantation Heart Stroke Director William Beaumont Hospital Director, Cardiac Rehabilitation and Exercise Laboratories Duke Clinical Research Institute Director, Cardiac Care Unit; Assistant Johnson & Johnson Tethys BMS/Sanofi -aventis Siemens Solutions St. Jude Zin ZOLL Squibb (DSMB) Roche Astra-Zeneca Daiichi-Sankyo Thoratec Accorda Amgen NIH Novartis Paracor Medtronic Abbott Society of Chest Pain Centers (Board of Directors) Plaintiff, Missed ACS, 2010 AstraZeneca Boehringer Ingelheim* Squibb GlaxoSmithKline Hoffman La Astellas AstraZeneca Boehringer Ingelheim* Squibb Eli Lilly

3 Harlan M. Krumholz Jane A. Linderbaum David A. Morrow Yale School of Epidemiology and Public Health Mayo Clinic Assistant Harvard School Roche Novartis Otsuka Sanofi-aventis* The s Company Centegen/Life Tech United HealthCare (Science Advisory Group) GlaxoSmithKline Medtronic Merck Sanofi-aventis* The s Company American College of American Heart Association Massachusetts Society UnitedHealth VHA Beckman- Coulter Boehringer Ingelheim CardioKinetix CV Therapeutics/ Gilead Pharmaceuticals Critical Diagnostics Daiichi-Sankyo Genentech Ikaria Menarini Novartis OrthoClinical Diagnostics Roche Diagnostics Sanofi-aventis Schering-Plough Research Institute Siemens AstraZeneca Beckman-Coulter CV Therapeutics Daiichi-Sankyo Eli Lilly GlaxoSmithKline Merck Novartis Roche Diagnostics Sanofi-aventis Schering-Plough Research Institute Siemens Solutions Singulex AstraZeneca

4 L. Kristin Newby Joseph P. Ornato Narith Ou Martha J. Radford Jacqueline E. Tamis-Holland Duke Center, Division of Department of Emergency Virginia Commonwealth Professor and Chairman Mayo Clinic Pharmacotherapy Coordinator, NYU Langone Chief Quality Officer; NYU School of () St Luke's- Roosevelt Hospital Solutions Amgen* AstraZeneca BioVascular Shionogi Pharma NIH Resuscitation Outcomes Consortium ZOLL Circulation Amylin BG Squibb diadexus* Eli Lilly GlaxoSmithKline* Johnson & Johnson Merck* DCRI MURDOCK Study* NIH-NHLBI* Regado Schering Plough* NIH/NINDS Neurological Emergency Treatment Trials Consortium PI American Heart Association Elsevier/American Heart Journal Society of Chest Pain Centers Resuscitation

5 Carl L. Tommaso Cynthia M. Tracy Director, Interventional Fellowship Program; Columbia, College of Physicians and Surgeons Assistant Clinical Skokie Hospital Director of Catheterization Laboratory; NorthShore HealthSystems Partner George Washington Director, Division of Y. Joseph Woo Hospital of the of Pennsylvania Surgery David X. Zhao Vanderbilt Director, Cardiac Abbot Vascular Accumetrics AGA Osiris Volcano

6 Catheterization and Interventional This table represents all relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. *Indicates significant (>$10,000) relationship. Indicates no financial benefit. ACS indicates acute coronary syndromes; DSMB, data safety monitoring board; NHLBI, National Heart, Lung, and Blood Institute; NIH, National Institutes of Health; and PI, principal investigator.

HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging

HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of

More information

Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness

Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness 2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar

More information

Method of Declaration. Hospitality/Interest/Sponsorship

Method of Declaration. Hospitality/Interest/Sponsorship Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12

More information

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable

More information

Institutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant

Institutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable

More information

ACC.13 Committee Disclosures Page 1 of 9

ACC.13 Committee Disclosures Page 1 of 9 ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

Heart Valve Summit: Medical, Surgical and Interventional Decision Making

Heart Valve Summit: Medical, Surgical and Interventional Decision Making Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American

More information

2018 AATS/ACC/SCAI/STS

2018 AATS/ACC/SCAI/STS Reviewer Relationships With Industry and Other Entities (Comprehensive) 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Requirements for Transcatheter Aortic

More information

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID

More information

Previous Attendees List:

Previous Attendees List: Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare

More information

1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner

1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:

More information

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision

More information

Disclosures of Relevant Financial Relationships

Disclosures of Relevant Financial Relationships Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence

More information

Early Valuation. Company Portfolio

Early Valuation. Company Portfolio Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d

More information

Corporate Compliance & Transparency

Corporate Compliance & Transparency 4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating

More information

ACC.17 Program Committee Disclosures of Relationships With Industry Disclosures

ACC.17 Program Committee Disclosures of Relationships With Industry Disclosures ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen

More information

European companies outpace American counterparts in R&D investment growth for the first time in five years

European companies outpace American counterparts in R&D investment growth for the first time in five years IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

The 2011 EU industrial R&D investment SCOREBOARD

The 2011 EU industrial R&D investment SCOREBOARD 1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at

More information

State of Licensing 2011 Update

State of Licensing 2011 Update State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-

More information

STEVEN W. ORLOW, MD, MMI, FACP, FACC

STEVEN W. ORLOW, MD, MMI, FACP, FACC STEVEN W. ORLOW, MD, MMI, FACP, FACC Professional Summary I am a licensed physician executive with a master's degree followed by board certification in medical informatics and 7 years of Chief Medical

More information

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager

More information

TRANSLATIONAL SCIENCE

TRANSLATIONAL SCIENCE TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM

More information

Committee Disclosures Page 1 of 12

Committee Disclosures Page 1 of 12 TCT@ACC-i2 Program Committee Disclosures Last Name First Name Middle Name Nothing to Grants Abbott J. Dawn X Abizaid Alexandre Abbott, Boston Scientific Angiolillo Dominick J. Eli Lilly, Daiichi-Sankyo,

More information

Innovation and the Changing Practice of Medicine

Innovation and the Changing Practice of Medicine Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis

More information

7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course

7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course 7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August 2010 Exhibitor Prospectus About the Course During Scripps Clinic s Oncology Update course, clinical experts will review

More information

TRENDS IN IP DISPUTES

TRENDS IN IP DISPUTES ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating

More information

Annual Benefit-Risk Workshop

Annual Benefit-Risk Workshop Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The

More information

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT. Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,

More information

Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics

Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent

More information

HESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09

HESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09 HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!

More information

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data

More information

Midwestern Conference on Optimizing Electrophysiology Patient Care and Procedural

Midwestern Conference on Optimizing Electrophysiology Patient Care and Procedural Midwestern Conference on Optimizing Electrophysiology Patient Care and Procedural Success in the EP Lab COMMERCIAL SUPPORT This continuing medical education activity is supported in part with educational

More information

Lehigh University Team biographies. October 30, 2017

Lehigh University Team biographies. October 30, 2017 Lehigh University Team biographies October 30, 2017 Core team members 2 Lane McBride Partner and Managing Director, Washington, DC Lane McBride is a Partner and Managing Director in the Washington, D.C.

More information

B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems

B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of

More information

Comprehensive Research Services

Comprehensive Research Services Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.

More information

Cardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC

Cardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC Cardiac Safety Research Consortium: A Decade of CSRC Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC

More information

Patent Documentation Group

Patent Documentation Group Patent Documentation Group 1957-2008 Minoo Philipp President Patent Documentation Group http://www.p-d-g.org Patents are a very important source of technical information Need for abstracts of patent information

More information

Sharing Clinical Research Data: An Institute of Medicine Workshop

Sharing Clinical Research Data: An Institute of Medicine Workshop Forum on Drug Discovery, Development, and Translation Forum on Neuroscience and Nervous System Disorders National Cancer Policy Forum Roundtable on Translating Genomic-Based Research for Health Sharing

More information

Managing Conflict of Interest

Managing Conflict of Interest Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians

More information

The importance of transnational corporations in research and development activities in the world

The importance of transnational corporations in research and development activities in the world Jagiellonian Journal of Management vol. 3 (2017), no. 2, pp. 65 75 doi:10.4467/2450114xjjm.17.005.7735 www.ejournals.eu/jjm The importance of transnational corporations in research and development activities

More information

Experiences of an aspiring young scientist-entrepreneur

Experiences of an aspiring young scientist-entrepreneur Experiences of an aspiring young scientist-entrepreneur Francis W. Hunter Auckland Cancer Society Research Centre Spark Entrepreneurship Challenge Mesopharm Therapeutics, Inc. 5 May 2014 Background Auckland

More information

ABOUT THE SPEAKER. J. Roderick Heller, III

ABOUT THE SPEAKER. J. Roderick Heller, III ABOUT THE SPEAKER J. Roderick Heller, III J. Roderick Heller, III, is President and Chief Executive Officer of the National Corporation for Housing Partnerships, a Congressionally authorized entity created

More information

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery

More information

HFMA Summer Conference

HFMA Summer Conference HFMA Summer Conference August 11, 2017 Intermountain Lake Park Facility 4646 Lake Park Blvd Salt Lake City, Utah 84120 7.0 CPE hours 7:30 8:15 a.m. Continental Breakfast 8:15 8:30 a.m. Opening and Chapter

More information

Biotech Concerto #6 Investment Process December 2008

Biotech Concerto #6 Investment Process December 2008 Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision

More information

Baxter 2007 Investor Conference March 14, 2007

Baxter 2007 Investor Conference March 14, 2007 Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide

More information

Seminars in Health Care,

Seminars in Health Care, Seminars in Health Care, 2004-05 Welcome Welcome to the Health Sector Management seminar series. We are proud of the distinguished group that we have scheduled to speak. We hope that you find the speakers

More information

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013

MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013 MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters

More information

The 2010 EU industrial R&D investment SCOREBOARD

The 2010 EU industrial R&D investment SCOREBOARD 1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D

More information

Officer Director etc. Ownership Partnership Principal. Speaker's Bureau

Officer Director etc. Ownership Partnership Principal. Speaker's Bureau ACC.14 and TCT@ACC-i2 Program Committees' Disclosures of Relationships with Industry Moniring Last Abbott J. Dawn YES YES Pfizer Bosn scientific Adams David H. YES YES Medtronic, Edwards Lifesciences,

More information

ACC.18 ABSTRACT REVIEWERS Disclosures

ACC.18 ABSTRACT REVIEWERS Disclosures Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,

More information

BOARD OF DIRECTORS. PETER WEHRLY Chair

BOARD OF DIRECTORS. PETER WEHRLY Chair BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held

More information

MANAGING DIRECTOR 360 MADISON AVENUE NEW YORK, NY

MANAGING DIRECTOR 360 MADISON AVENUE NEW YORK, NY Matthew Goldreich MANAGING DIRECTOR MGOLDREICH@CAINBROTHERS.COM 360 MADISON AVENUE NEW YORK, NY 10017 212.981.6946 Matt joined Cain Brothers in 1995 and is one of the longest tenured bankers at the firm.

More information

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance

More information

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone

More information

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,

More information

Annual Press Conference Financial year 2017

Annual Press Conference Financial year 2017 Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals

More information

Yevo Scientific Advisory Board

Yevo Scientific Advisory Board TM Yevo Scientific Advisory Board Dr. Stacey J. Bell Head of the Yevo Scientific Advisory Board Dr. Stacey Bell has been a nutritional consultant from 2008 to 2014, when she joined Yevo International.

More information

CONFE R E NC E AG E NDA

CONFE R E NC E AG E NDA CONFE R E NC E AG E NDA A DVA MED PAYMENT POL ICY As the reimbursement and coverage landscapes for the medical technology industry are continuously changing, s 4th Annual Payment Policy Conference will

More information

LIGHTHOUSE. The Science of Pharmaceutical Manufacturing

LIGHTHOUSE. The Science of Pharmaceutical Manufacturing The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for

More information

Monetizing Early-Stage R&D Assets. March 18, 2015

Monetizing Early-Stage R&D Assets. March 18, 2015 Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst

More information

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until

More information

INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH

INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH Sharing Information, Knowledge and Materials Dr. Ashley J. Stevens Executive Director, Technology Transfer Senior Research Associate

More information

Page 1 of 305. ACC.13 Presenter Disclosures of Relationships with Industry Officer Director etc.

Page 1 of 305. ACC.13 Presenter Disclosures of Relationships with Industry Officer Director etc. ACC.13 Presenter Disclosures of Relationships with Industry Last First Aaronson Alistair Aaronson Keith D. YES HeartWare Thoratec, HeartWare Ababneh Bashar Abagriy A YES Lectures for Nycomed, Pfizer, Servier,

More information

Carolinas HealthCare Foundation. Annual Report 2016

Carolinas HealthCare Foundation. Annual Report 2016 Carolinas HealthCare Foundation Annual Report 2016 Today, multiple programs and services throughout Carolinas HealthCare System are being supported or significantly enhanced by philanthropy. Children s

More information

Researched Medicines Industry Association of New Zealand Incorporated

Researched Medicines Industry Association of New Zealand Incorporated MResearched Medicines Industry Researched Medicines Industry Association of New Zealand Incorporated Submission on Patents Bill to the Commerce Select Committee July 2009 Researched Medicines Industry

More information

Using Academic Licensing Agreements to Promote Global Social Responsibility

Using Academic Licensing Agreements to Promote Global Social Responsibility Using Academic Licensing Agreements to Promote Global Social Responsibility Equitable Licensing of Medical Research Results Charité - Universitätsmedizin Berlin April 26, 2009 Dr. Ashley J. Stevens Executive

More information

Mid-Atlantic - Russia Business Council (MARBC)

Mid-Atlantic - Russia Business Council (MARBC) MARBC Mid-Atlantic - Russia Business Council (MARBC) 16 th Semi-Annual Russian-American Innovation Technology Weeks (RANIT-BIO) Agenda June 14-21, 2012 Philadelphia, PA Boston, MA The 16 th Semi-Annual

More information

2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA

2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.

More information

San Diego. March 2, American College of Surgeons Surgical Health Care Quality Forum. American College of Surgeons

San Diego. March 2, American College of Surgeons Surgical Health Care Quality Forum. American College of Surgeons American College of Surgeons Inspiring Quality: Highest Standards, Better Outcomes American College of Surgeons Surgical Health Care Quality Forum San Diego March 2, 2012 Scripps Memorial Hospital La Jolla

More information

WINTER FRIDAY ~ SUNDAY, 10 ~ 12 JANUARY Department of Surgery University of Hong Kong Medical Centre Queen Mary Hospital Hong Kong

WINTER FRIDAY ~ SUNDAY, 10 ~ 12 JANUARY Department of Surgery University of Hong Kong Medical Centre Queen Mary Hospital Hong Kong WINTER FRIDAY ~ SUNDAY, 10 ~ 12 JANUARY 2003 Department of Surgery University of Hong Kong Medical Centre Queen Mary Hospital Hong Kong HONG KONG SURGICAL FORUM The Hong Kong Surgical Forum is an international

More information

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current: Curriculum Vita Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation Career History: Current: Managing Editor, The Keckley Report (2006-present) The Keckley Report is a weekly blog

More information

2,500,000 Shares. Common Stock

2,500,000 Shares. Common Stock Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-201841 Prospectus Supplement No. 15 to Prospectus dated February 26, 2015 2,500,000 Shares Common Stock This Prospectus Supplement No. 15

More information

The Role of Patients in Transitions of Care

The Role of Patients in Transitions of Care Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,

More information

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be

More information

Giuseppe Savoja Curriculum Vitae mob.: Past

Giuseppe Savoja Curriculum Vitae mob.: Past International Marketing Manager at Medtronic Geneva Area, Switzerland, Medical Devices Past Marketing Program Manager International Surgical Ablation & Beating Heart Revascularization at Medtronic Product

More information

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions

More information

Management to Host Conference Call at 8:30 a.m. ET today

Management to Host Conference Call at 8:30 a.m. ET today Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),

More information

CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within

More information

RICHARD BUTLAND Director

RICHARD BUTLAND Director RICHARD BUTLAND Richard Butland is the managing partner of Kite Capital, a growth oriented private investment firm. Prior to establishing Kite Capital, Richard spent 15 years at Goldman Sachs where he

More information

SPONSORSHIP 2009 guide

SPONSORSHIP 2009 guide SPONSORSHIP 2009guide Prix Galien USA Committee The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative therapies. The Prix

More information

Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?

Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? Workshop on Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? 2 nd & 3 rd December 2013 Sheraton Heathrow Airport Hotel, UK PROGRAMME Organisers:

More information

Chairman Estrada asked the Secretary to call upon the registered public speakers. The Secretary called upon the following registered speaker:

Chairman Estrada asked the Secretary to call upon the registered public speakers. The Secretary called upon the following registered speaker: Minutes of the meeting of the Finance Committee of the Board of Directors of the Cook County Health and Hospitals System held Thursday, February 15, 2018 at the hour of 8:30 A.M., at 1900 W. Polk Street,

More information

Greg Gubitz CEO Gilbert Godin President & COO Winter 2018

Greg Gubitz CEO Gilbert Godin President & COO Winter 2018 INVESTOR PRESENTATION Greg Gubitz CEO Gilbert Godin President & COO Winter 2018 Forward-looking statements Certain statements in this presentation are forward-looking statements. Any statements that express

More information

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers

More information

Please join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you!

Please join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you! INVITATION TO SPONSOR Currently in its eighth year, the North Carolina CEO Forum is an invitation-only leadership event that welcomes 400 senior business, government and non-profit leaders who are committed

More information

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant

More information

ROLL CALL PURCHASE RECOMMENDATIONS

ROLL CALL PURCHASE RECOMMENDATIONS 13 Board Meeting September 7, 2017 ROLL CALL PURCHASE RECOMMENDATIONS The "Purchase Recommendations" are presented by campus and a Summary from "Appropriated Funds" (i.e., from State appropriations to

More information

30th Annual Oncology Nurses Symposium

30th Annual Oncology Nurses Symposium E X H I B I T O R P R O S P E C T U S 30th Annual Oncology Nurses Symposium S E P T E M B E R 2 6-2 9, 2 0 1 0 H I L T O N S A N D I E G O R E S O R T Scripps Conference Services & CME www.scripps.org/conferenceservices

More information